Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06443125

Study on Therapeutic Mechanism of Natural Psychotherapy for Neurosis

explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder

Recruiting

Interested in participating?

Request Info

Key information

Age range

15 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Anhui Mental Health Center, Hefei, Anhui, China

Loading trial locations.

About this study

  • To evaluate the cognitive function, Cognitive control, emotion and other aspects of neurosis patients, and to understand and master the cognitive behavior indicators of this population.
  • Investigate the pathological mechanism of neurotic patients from the aspects of electroencephalic graph/functional magnetic resonance imaging (EEG/fMRI) and biology.
  • To investigate the therapeutic effect of natural psychotherapy on cognitive impairment and related mood, sleep and symptom intervention in neurotic patients. In order to achieve the symptoms of neurosis patients, cognitive impairment and related mood and sleep intervention and promotion, while providing a scientific basis for neurosis rehabilitation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have a diagnosis of obsessive-compulsive disorder or compulsive behavior
  • Duration of symptoms for not less than 12 months
  • Age 15-60 years old.
  • You can participate in the whole experiment and offline assessment in Beijing

Exclusion criteria

  • Documented disease of physical diseases including, but not limited to stroke, tumor, Parkinson's disease, Huntington's disease, seizure, epilepsy, history of brain trauma
  • Subjects who suffered from alcohol or illegal drug abuse/dependence

Treatment and study plan

Natural psychotherapy

Other

Draw ideas from traditional Chinese culture, learn from the practice of Morita therapy in Japan, and create local practice experience. At the same time, a variety of research methods such as cognitive assessment and brain imaging were used to establish the scientific, professional and objective evaluation indexes of the therapy.

Primary outcomes

  1. Obsessive-compulsive symptoms

    Time frame: Baseline, 12 weeks

    Obsessive-compulsive symptoms were assessed according to the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), The total score ranges from 0 to 40, with higher scores indicating more severe symptoms.

  2. Cognitive function

    Time frame: Baseline, 12 weeks

    Cognitive inhibition was assessed using the emotional color-word Stroop task. The emotional Stroop task is a type of being Widely used cognitive inhibition assessment tools. The longer the reaction time, the worse the cognitive inhibition ability.

  3. Mood and behavior

    Time frame: Baseline, 12 weeks

    Mood changes judged using gait and face recognition

  4. ERP components associated with cognitive function

    Time frame: Baseline, 12 weeks

    To explore the ERP component analysis related to cognitive inhibition and Behavioral inhibition in obsessive-compulsive disorder (OCD) by event related potential (ERP) analysis

  5. rest fMRI in Obsessive-compulsive patients

    Time frame: Baseline, 12 weeks

    The changes of resting-state functional connectivity were analyzed in patients with OCD before and after intervention. Resting-state functional connectivity:FC(Functional connectivity). Resting-state functional brain imaging data were collected using a GE 3.0T magnetic resonance scanner (GE Discovery MR750) at the Brain Imaging Center, Institute of Psychology, Chinese Academy of Sciences.

  6. Behavioral inhibition

    Time frame: Baseline, 12 weeks

    behavioral inhibition was assessed using the emotional stop signal task (SST). The emotional SST task is a type of being Widely used behavioral inhibition assessment tools. Among them, the greater the SSRT, the worse the behavioral inhibition ability.

Study contacts

Contact information is provided by the study sponsor or research team.

Zhang Y Xiang, M.D., Ph.D

CONTACT

[email protected]

+86-10-62710644

Sponsors and collaborators

Lead sponsor

Xiang Yang Zhang

Other

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Jun 5, 2024
Registry last updated
Dec 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.